Delgocitinib has emerged as a promising treatment for CHE, addressing unmet needs and enhancing understanding of this complex condition, notes Raj Chovatiya, MD, PhD, MSCI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback